RegMed Investors’ (RMi) closing bell, the IBB dives -1.87% from yesterday’s +0.65%

July 27, 2017 5:52pm

Cell therapy equities’ momentum is waning and upcoming Q2 financial results will further ambiguity

Out and about:  Neuralstem (CUR) gets punished (-$0.72, –29.15% to $1.75) again as it announced an offering after news of a mid-stage clinical trial miss for its major depressive disorder drug …

Pre-open indications: 5 hits and 2 miss

It’s called premium content for a reason … I define insight  from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!

Others don’t even come close!

I answer one question, in which company should investors commit and keep their money.

Thursday’s results have implications to Friday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

Henry’omics:

From the pre-open’s investor’s newsletter, “rounding-up the unknown unknowns, Good news spells upside, and no news is considered bad news. The battle of the oversold and the overbought continues but, who or what is making that determination – ETFs and algorithms.”

• Volume was still sluggish and all over the map; which seems higher in selling – again; it is a gauge of how the sector feels at the moment.

Cell therapy has the potential to saving lives? It’s has been said to be true but, there are issues that contain their development and – many are self-induced!

• Cell therapy equities are boom and bust – by the day and mostly by the hour!

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was barely negative with an A/DL of 17/19 and 3 flats;

·         The mid-day was negative with an A/DL of 17/22 and 4 flats;

·         The close was negative  with an A/DL of 10/31 and 2 flats;

Pre-open indications: 5 hits and 2 miss

• Capricor (CAPR) closed up +$0.29 – hit;
• MiMedx (MDXG) closed DOWN -0.30 – miss;
• International Stem Cell (ISCO) closed up +$0.04 – hit;
• bluebird bio (BLUE) closed down -$3.65 – hit;
• BioLife Solutions (BLFS) closed up +$0.02 – miss;
• Spark Therapeutics (ONCE) closed down -$2.39 – hit;
• Neuralstem (CUR) closed down -$0.72 – hit;

Out and about:

Neuralstem, Inc. (CUR) commenced a public offering, subject to market and other conditions, to issue and sell shares of its common stock and warrants to purchase shares of its common stock.

CUR was down -$0.69 or –27.73% to $1.78 after news and a mid-stage clinical trial miss for its major depressive disorder drug …

Daily analytics:

The Dow closed at a record on Thursday; the Dow ended 85.54 points, or 0.4%, higher at 21,796.55. The NASDAQ closed 40 points, or 0.6% to 6,382, but off its worst levels. The S&P 500 index ended off 2.41 points, or 0.1%, to 2,475.42.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded Thursday up +5.31% to 10.11 following Wednesday’s 9.60 following Tuesday’s near 9.43 – flat as compared to Monday’s 9.43 …

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Thursday was down -0.64%

·         Wednesday was down -0.57%

·         Tuesday was up +0.89%

·         Monday’s up +0.14%

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Thursday was down -1.87%

·         Wednesday was up +0.65%

·         Tuesday was down -1.08%

·         Monday’s up +0.76%

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %’s migrate……….

·         Thursday’s decliners ranged from -0.45% <OPXA> to -29.15% <CUR> in 31 equities;

·         Wednesday’s decliners ranged from -0.30% <XON> to -12.10% <CUR> in 18 equities;

·         Tuesday’s decliners ranged from -0.10% <JUNO> to -49.64% <CUR> in 29 equities;

·         Monday’s decliners ranged from -0.35% <BSTG> to -56.77% <CYTX> in 18 equities

Versus

………… look at the percentage’s (%) and their decreases …….

·         Thursday’s gainers ranged from +0.28%  <FCSC> to +28.71% <CAPR> in 10 equities;

·         Wednesday’s gainers ranged from +0.28%  <VSTM> to +18.85% <ISCO> in 21 equities;

·         Tuesday’s gainers ranged from +0.56%  <XON> to +2.16% <NWBO> in 10 equities;

·         Monday’s gainers ranged from +0.61%  <ATHX> to +10.22% <NWBO> in 20 equities;

Some of MY working trend lines or indications:

… The greatest volume to the downside:  NWBO, CUR, MDXG, JUNO and IMUC

… Upside volume was weighted to:  CAPR, BSTG, CYTX, VSTM and VTGN

… Biggest $ downside:  BLUE, ONCE, KITE, JUNO and RGNX

… Largest $ upside:  CAPR, VTGN, BSTG, ISCO and HSGX

… Flat: VCEL and RENE.L

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.